GI Disorders - Inflammatory, Lower GI
MODULE 9: GI DISORDERS
11: Inflammatory, Lower GI
NURS 317
INFLAMMATORY BOWEL DISEASE (IBD)
Overview
Definition: IBD refers to chronic inflammatory disorders of the gastrointestinal (GI) tract.
Affected Area: The entire GI tract is susceptible.
Major Types: There are two major types of IBD:
Crohn's Disease: Characterized by transmural granulomatous inflammation.
Ulcerative Colitis (UC): Also known as vicerative colitis (VCI).
Common Features:
Both types involve relapsing-remitting flares leading to full-thickness inflammation.
Both increase the risk of colon cancer over time.
Clinical Features
Symptoms:
Abdominal pain
Diarrhea
Weight loss
Fluid/electrolyte imbalance
Low-grade fever
Fatigue
**Complications of IBD: **
Fistulas: Pathological tunneling that can lead to perforation.
Abscesses: Pockets of pus.
Obstruction: Blockage can occur in the intestines.
Diagnostics
Procedures:
Sigmoidoscopy
Stool culture
CT scan
ULCERATIVE COLITIS (UC)
Pathophysiology
Type: Mucosal/submucosal inflammation.
Pattern of Spread: Continuous spread starting from the rectum.
Clinical Features
Symptoms:
Bloody diarrhea mixed with mucus
Urgency to defecate
Left lower quadrant (LLQ) cramps
Complications:
Toxic megacolon: Severe inflammation causes the colon to fail to push contents forward, leading to colon distention.
Colorectal cancer.
Tenesmus: Severe discomfort in the lower abdomen, feeling of needing to pass stool without relief.
Diagnostics
Procedures:
Colonoscopy with biopsy to examine mucosal and submucosal layers.
Stool cultures are also performed.
Result: Provide immediate indication of pathology in the colon.
Treatment Goals
Primary Goal: To increase remission time and reduce complications.
PHARMACOLOGY IN IBD
Goals of Pharmacological Management
Medications Used for IBD:
5-ASA Prototype: Sulfasalazine (Azulfidine)
Objective: Induce and maintain remission. (No cure)
Use in: Maintenance of remission in UC. Cannot cure chronic IBD.
Drug Classes:
5-ASA drugs (Amino salicylates)
Biologics (TNF inhibitors)
Corticosteroids
DMARDs (Disease-modifying antirheumatic drugs)
Immunosuppressants
Indications
Mild to moderate UC; off-label for chronic forms.
NURSING CONSIDERATIONS
Monitoring and Education
Monitoring: Routine checks on CBC and folate levels.
Patient Education:
Adverse effects: Nausea, vomiting, diarrhea, photosensitivity, headaches.
Guidelines for preventing dehydration, sun protection strategies.
Warning about temporary infertility risk during treatment (particularly for males) with education on returning fertility.
Risks and Contraindications
5-ASA Options:
Mesalamine
Balsalazide
Contraindications:
Sulfa or aspirin allergy
Urinary obstruction
Anemia or folate disorders
Hepatic impairment
Escalation Therapy
Prototype Medications:
TNF Inhibitor Prototype: Adalimumab (Humira)
Integrin Blocker Prototype: Vedolizumab
Risks of Drug Therapy
Serious infections (e.g., TB reactivation)
Immunosuppressants: Azathioprine (and risks for malignancies)
Nursing Screening: For TB/hepatitis before starting immunosuppressants.
Monitoring
Monitor infusion reactions and signs of hepatotoxicity.
LOWER GI DISORDERS
Diverticulosis vs. Diverticulitis
Diverticulosis: Presence of outpouchings, which are often asymptomatic.
Diverticulitis: Occurs when non-digested food particles become trapped in diverticula (e.g., popcorn kernels, seeds).
Symptoms of Diverticulitis: Abdominal pain, fever.
Complications:
Perforation, abscesses, obstruction.
Management of Diverticulitis:
NPO (nothing by mouth) order, IV antibiotics, surgery if complicated.
APPENDICITIS
Cause
Fecalith obstruction is the most common etiology.
Symptoms
RLQ (right lower quadrant) pain.
Rebound tenderness, fever, and elevated WBC (white blood cells).
Risk of Untreated Appendicitis
Perforation leading to peritonitis.
Management
Appendectomy is the surgical intervention required.
INTESTINAL OBSTRUCTION
Types
Mechanical Obstruction: Caused by adhesions or hernias.
Paralytic Ileus: Neurogenic or post-operative cessation of bowel function.
Symptoms
Colicky abdominal pain, no bowel movement, and resulting distension.
Management
First-line Treatment: Bowel rest with NPO order. Correct underlying issues, not just decompression. Surgery may be necessary to relieve strangulation.
PARALYTIC ILEUS
Background
Definition: A type of bowel obstruction where food or drink does not pass through the intestines due to the loss of peristalsis.
Causes
Stress response from abdominal or pelvic surgery.
Infection or inflammation from conditions such as:
Gastroenteritis
Pancreatitis
Peritonitis
Diverticulitis
Electrolyte imbalances.
Vascular/neural impairment.
Use of certain medications (e.g., opioids).
Treatment
Focus on relieving symptoms and addressing the underlying cause.
Management includes bowel rest, IV fluid therapy (if NPO), total parenteral nutrition (TPN), and possibly using a nasogastric tube for decompression. Surgery may be indicated for extended cases.
SYMPTOM SYNDROMES IN GI DISORDERS
Nausea and Vomiting
Centers Involved
Vomiting Center: Located in the medulla oblongata, integrated with several triggers and signals from the gastrointestinal tract, vestibular systems, toxins, and chemotherapy drugs.
Complications of Nausea and Vomiting
Risks of dehydration, motion sickness, food poisoning, chemical toxicity, bowel obstruction.
Antiemetic Pharmacology
5-HT3 Antagonist Prototype: Ondansetron (Zofran)
MOA: Blocks serotonin receptors in the gut, reducing nausea and vomiting.
Common Uses: Nausea and vomiting; particularly severe cases during pregnancy.
Adverse Effects: Headaches, constipation, QT prolongation, serotonin syndrome, tinnitus.
DOPAMINE ANTAGONISTS
D2 Antagonist Prototype
Example: Prochlorperazine (Compazine)
Class: Dopamine (D2) receptor antagonists, phenothiazine class.
MOA: Blocks dopamine receptors in the chemoreceptor trigger zone, suppressing nausea and vomiting.
Adverse Effects and Contraindications
Common Side Effects: Sedation, dizziness, hypotension, anticholinergic effects (dry mouth, constipation, urinary retention, blurred vision).
Contraindications: Comatose patients, children under 2 years, moderate nausea/vomiting post-op, narrow-angle glaucoma.
Nursing Considerations
Monitor for extrapyramidal symptoms (EPS) and educate on reporting red flags such as tardive dyskinesia, akathisia, and other abnormal movements.
DIARRHEA
Pathophysiology
Acute Diarrhea: Usually infectious (can be watery or bloody).
Chronic Diarrhea: Associated with IBD, irritable bowel syndrome (IBS), malabsorption syndromes, endocrine disorders.
Complications of Diarrhea
Risks include dehydration, hypokalemic metabolic acidosis due to excessive bicarbonate loss.
Antidiarrheal Prototype
Example: Diphenoxylate/Atropine (Lomotil)
Classification: Opioid antagonist with atropine added to discourage abuse.
MOA: Acts on intestinal smooth muscle to slow peristalsis, enhancing fluid absorption and reducing stool frequency.
Nursing Considerations
Indications: Moderate to severe diarrhea of non-infectious origin.
Adverse Effects: CNS depression effects like dizziness and drowsiness, anticholinergic effects such as dry mouth.
Contraindications: Risk of exacerbation in C. diff infections. Monitor for electrolytic imbalances.
CONSTIPATION
Causes
Factors contributing include low fiber intake, low fluid intake, inactivity, certain medication use (especially opioids and anticholinergics).
Complications
Severe complications include fecal impaction, which can lead to mechanical obstruction, ileus, and overall obstruction.
Laxative Pharmacology and Management
Nutritional Measures: Increase dietary fiber.
Prophylactic Use in Opioid-Induced Constipation (OIC): Start with stool softeners like docusate or stimulant laxatives such as senna or bisacodyl.
Contraindications: Avoid giving laxatives if signs of obstruction or absent bowel sounds are present.
Teaching Points for Patients: Importance of adequate hydration, fiber intake, and a routine bowel regimen.
SUMMARY
Understanding these GI disorders, including their pathophysiology, clinical features, diagnostics, and treatment options, is crucial for effective nursing practice and patient care. Regular monitoring and patient education are essential components of the nursing role in managing these conditions.